Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2025 vs. Q1 2025
How the institutions holding Terns Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 138 | 130 | −8 |
| Shares | 83.1M | 83.1M | +19.0K (0.0%) |
| Value | $229.4M | $310.0M | +$80.6M (+35.1%) |
New holders (24)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (32)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.